Showing results (21-30 of 74) with videos related to
Sort By:
Pageof 8
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 22, 2015
Impact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapyStuart E Samuels, Jeffrey Vainshtein, Matthew E Spector, et al.International Journal of Radiation Oncology, Biology, Physics|March 11, 2015
Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinomaAaron Sabolch, Tobias Else, Kent A Griffith, et al.Thyroid : Official Journal of the American Thyroid Association|March 19, 2020
Patient Report of Recurrent and Persistent Thyroid CancerMaria Papaleontiou, Josh M Evron, Nazanene H Esfandiari, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2005
Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigmSusan Urba, Gregory Wolf, Avraham Eisbruch, et al.Journal of Biotechnology|October 18, 2016
Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical studyMahesh Kudrimoti, Amarintha Curtis, Samar Azawi, et al.Head & Neck|February 26, 2017
Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancerAndrew Rosko, Andrew Birkeland, Andrew Shuman, et al.Biotechnology Reports (Amsterdam, Netherlands)|June 27, 2017
Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patientsMahesh Kudrimoti, Amarinthia Curtis, Samar Azawi, et al.International Journal of Radiation Oncology, Biology, Physics|November 26, 2008
Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective studyYue Cao, Aron Popovtzer, Diana Li, et al.Cancers|January 11, 2024
Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001Filippo De Braud, Barbara Deschler-Baier, John C Morris, et al.Head & Neck|June 15, 2013
Circulating CD4-positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancerNicholas A Dewyer, Gregory T Wolf, Emily Light, et al.Pageof 8